[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
ImmunityBio, Inc. Common Stock (IBRX)
ImmunityBio stock sees a surge in social media engagement with positive sentiment and short squeeze potential. The stock is trading at $2.60, but concerns about market manipulation persist.
About ImmunityBio, Inc. Common Stock
ImmunityBio, Inc. Common Stock (IBRX) is a publicly traded stock in the healthcare sector.
ImmunityBio, Inc. Common Stock uses the ticker $IBRX for trading. Listed in the Stocks and category.
Insights #
- ImmunityBio, Inc. Common Stock (IBRX) trading volume is up XXXXX% from the previous week.
- ImmunityBio, Inc. Common Stock (IBRX) galaxy score™ is up XXXXXX% from the previous X months.
- ImmunityBio, Inc. Common Stock (IBRX) sentiment is up XXXXX% from the previous week.
- ImmunityBio, Inc. Common Stock (IBRX) creators is up XXXXX% from the previous week.
- ImmunityBio, Inc. Common Stock (IBRX) mentions is up XXXXX% from the previous week.
Price: $XXXX #
Price 24-Hour Time-Series Raw Data
The stock price is experiencing an upward trend, likely fueled by positive sentiment, potential for a short squeeze, and recent positive news, despite concerns about market manipulation and financial performance. The price is currently at $2.60, with a 24-hour change of -0.39%.
| 24-Hour | 7-Day | 30-Day |
|---|---|---|
| XXXX% | XXXX% | -XXXX% |
1-Year High: $XXXX on 2024-10-28
1-Year Low: $XXXX on 2025-05-07
AltRank: XXX #
AltRank 24-Hour Time-Series Raw Data
ImmunityBio, Inc. Common Stock (IBRX) is currently AltRank #709 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXXXX +611
1 Month: XXX +536
6 Months: XXX -XXX
1 Year: XXX -XX
1-Year High: XXXXX on 2025-06-27
1-Year Low: XX on 2025-01-11
Galaxy Score: XXXXX #
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +30
1 Month: XX +35
6 Months: XX +51
1 Year: XX +13
1-Year High: XX on 2025-08-13
1-Year Low: XX on 2024-10-26
Engagements: XXXXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXX -XX%
6 Months: XXXXXXXXX -XX%
1 Year: XXXXXXXXX -XXXX%
1-Year High: XXXXXXX on 2024-10-25
1-Year Low: XXXXX on 2025-08-09
| Social Network | X |
|---|---|
| Engagements | XXXXX |
Mentions: XX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
1 Week: XXX +49%
1 Month: XXX -XXXX%
6 Months: XXXXX -XX%
1 Year: XXXXX +40%
1-Year High: XXX on 2024-10-28
1-Year Low: XX on 2024-10-17
| Social Network | X |
|---|---|
| Mentions | XXX |
Creators: XX #
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning ImmunityBio, Inc. Common Stock (IBRX) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
1 Week: XXX +21%
1 Month: XXX -XXXX%
6 Months: XXXXX +21%
1 Year: XXXXX +162%
1-Year High: XXX on 2024-10-28
1-Year Low: XX on 2025-09-28
The most influential creators that mention ImmunityBio, Inc. Common Stock in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @DrPatSoonShiong | X | XXXXXX | X | XXXXXX |
| @bullishbruk | X | XXXXX | X | XXXXX |
| @ImmunityBio | X | XXXXX | X | XXX |
| @GuzmanAlic16045 | X | XX | X | XXX |
| @Biobeats99 | X | XXX | X | XXX |
| @Deadbrokeinvest | X | XXX | X | XXX |
| @BAMBossie81 | X | XXX | X | XXX |
| @ToniReoven | X | XXX | X | XXX |
| @DavidDin | X | XXXXX | X | XXX |
| @oshea9_harry | XX | XX | X | XXX |
Sentiment: XX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% +22%
1 Month: XX% -XX%
6 Months: XX% +14%
1 Year: XX% +33%
1-Year High: XXX% on 2025-05-11
1-Year Low: XX% on 2025-04-12
Most Supportive Themes
- Positive Sentiment and Recommendations: (45%) Posts highlight positive sentiment, stock recommendations, and potential for gains.
- Short Squeeze Potential: (25%) Mentions of high short interest and potential for a short squeeze.
- Positive News and Catalysts: (15%) Discussion of positive news, such as the potential of Anktiva and upcoming catalysts.
Most Critical Themes
- Market Manipulation Concerns: (10%) Posts express concerns about market manipulation and the stock's price movement.
- Financial Performance Concerns: (5%) Mentions of the company's financial performance, including the widened net loss.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXX | XX% | XXXXX | XX% | XXXXX | XX% |
| Total | XXXXX | XX% | XXXXX | XX% | XXXXX | XX% |
Social Dominance: XXXXXXX% #
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXX%
1 Week: XXXXX% -XXXXX%
1 Month: XXXXX% -XXXXXX%
6 Months: XXXXX% -XXXXX%
1 Year: XXXXX% -XXXX%
1-Year High: XXXXX% on 2024-10-28
1-Year Low: XXXXX% on 2025-10-15
Market Dominance: XXXXXX% #
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-31
1-Year Low: XXXXXXX% on 2025-05-07
Market Cap: $XXXXXXXXXXXXX #
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX +$2.40%
1 Month: $XXXXXXXXXXXXX -$5.80%
6 Months: $XXXXXXXXXXXXX +$12%
1 Year: $XXXXXXXXXXXXX -$5.40%
1-Year High: $XXXXXXXXXXXXX on 2024-10-28
1-Year Low: $XXXXXXXXXXXXX on 2025-05-07
Top assets mentioned In the posts about ImmunityBio, Inc. Common Stock in the last XX hours
Applied Blockchain, Inc. Common Stock (APLD) Iovance Biotherapeutics, Inc. Common Stock (IOVA) Intellia Therapeutics, Inc (NTLA) Merus N.V. Common Shares (MRUS) IonQ, Inc. (IONQ) BioMarin Pharmaceutical, Inc. (BMRN) BEAM (BEAM) Bitcoin Incognito (XBI) CRISPR Therapeutics AG (CRSP)
Top topics mentioned In the posts about ImmunityBio, Inc. Common Stock in the last XX hours
stocks healthcare, $apld, investment, stocks technology, $iova, stocks financial services, stocks, stocks bitcoin treasuries, money, $ntla, $mrus, $ionq, $bmrn, $beam, coins defi, $cvkd, $xbi, $crsp, stocks consumer cyclical, prize, $pfe, $prgo, $cort, alt aptoslaunch token, coins dao, $alt, where is, regeneron pharmaceuticals inc, bank of america, $qure, $akro, $pcvx, $ptct, donald trump, $clsk, $plug, $mrna, has been, longterm, stocks industrials, $grab, $2b, $sgmo, $nwbo, united states, $bntx, bax baxter international inc, $bax, $13m, $vnda, $gern, stocks crypto treasuries, galaxy digital, $glxy, $abtc, american bitcoin corp, coins stacks ecosystem, realtime, $crap, $edit, $fate, $rgnx, $97m, $153m, $80m, $233m, $rytm, rfk, $llc, $arwr, $amrx, $apge, $abcl, neurocrine biosciences inc, $245ish, $3b, $cadl, $290m, $inkt, over the, ticker, loaded, 100x, $bmy, twitter, blank, auroracoin, aur, $aur, $hcmc, $hd, $hexo, $hmbl, $autl, quarterly earnings, $gme, $aapl, $aep, $colb, $acgl
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"@catturd2 Yup and they're blocking the immunotherapy that can help us all. @ImmunityBio and @DrPatSoonShiong have the cure to cancer via boosting your immune system. Fight Pfizer buy $IBRX shares so we have a chance to reverse the spike protein pandemic"
X Link @wafflesnspace 2025-10-15T17:02Z XXX followers, XXX engagements
"$IBRX Back in 2020 @DrPatSoonShiong warned @US_FDA that (now confirmed) spike protein needs to be cleared from our body and has the antidote #bioshieled) offered it for free unfortunately till this day no one is listening @SecKennedy @DrMakaryFDA @megynkelly @joerogan @RealAlexJones"
X Link @bullishbruk 2025-10-15T15:38Z 2478 followers, 1351 engagements
"$IBRX Real impact: In QUILT trials patients saw durable responses up to XX months. One study: XX% DFS in papillary disease. This isn't hype it's NEJM Evidence-published science changing lives. @ImmunityBio #BioShield"
X Link @bullishbruk 2025-10-15T10:17Z 2478 followers, XXX engagements
"$IBRX Proven in clinics: BCG-unresponsive NMIBC ANKTIVA + BCG hit XX% complete response rate (vs. X% historical). Now expanding: Phase X trials show lymphopenia reversal in lung/prostate cancers improving PFS by 30-40%. FDA Expanded Access in June '25. #NMIBC #BladderCancer"
X Link @bullishbruk 2025-10-15T10:02Z 2478 followers, XXX engagements